Press Releases

The Kidney Cancer Association (KCA) awarded over half a million dollars in research grants to six investigators pursuing high-impact kidney cancer research through the annual KCA Research Award Program and partnerships. Each award supports early- to mid-career investigators researching topics that require greater attention and understanding across the kidney cancer community. The KCA distributed a total of $525,000 in research…

The Kidney Cancer Association (KCA) welcomes KidneyCouch as a new Affiliate Partner. Jeff Kallis KidneyCouch is committed to offering support and information to individuals battling kidney cancer and/or chronic kidney disease (CKD) with a goal to create a community that fosters connection, understanding, and empowerment for patients and their loved ones. Founder Jeff Kallis, 64, was diagnosed with stage 3…

The Kidney Cancer Association (KCA) welcomes Elevate Childhood Cancer Research and Advocacy (Elevate) as a new Affiliate Partner organization. Elevate’s mission is to dramatically improve the lives of those diagnosed with childhood cancer from diagnosis through treatment, supporting their whole life journey whether through terminal illness or survivorship. “Elevate is committed to ensuring that every child has access to precision…

The newly launched Pediatric Renal Tumor Coalition (PRTC) brings together leading experts and national organizations focused on childhood cancer research and advocacy to accelerate progress for children diagnosed with kidney cancers. Founding members of the PRTC include the Kidney Cancer Association (KCA), Joey’s Wings Foundation, Wilms Cancer Foundation (WCF), Elevate Childhood Cancer Research and Advocacy (Elevate), and Kelly Trout, BSN,…

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and the Kidney Cancer Association (KCA) are proud to announce a new joint Request for Applications (RFA) to advance the early detection and diagnosis of kidney cancer. This collaborative funding opportunity supports clinical validation studies and early-phase interventional trials (Phase I or II) that leverage innovative imaging technologies, biomarkers, or monitoring…

During Kidney Cancer Awareness Month, the Kidney Cancer Association encourages everyone to #OrangeUp and honor those impacted by this disease.   In the US, over 600,000 people live with kidney cancer and about 81,000 new cases will be diagnosed in 2025.   However, in the last decade, over a dozen new treatments for kidney cancer have been approved the research community continues…

The Kidney Cancer Association (KCA) will partner with Topline Bio, LLC for a new era of digital education and storytelling with and for healthcare professionals treating kidney cancer as well as patients and families impacted by the disease. This partnership solidifies our ability to create the sort of content that can revolutionize communication in our space by bringing easily digestible…

The Kidney Cancer Association (KCA) awarded five grants to investigators pursuing high-impact kidney cancer research across a variety of focus areas through its annual KCA Award Program. Each $75,000 award supports early- to mid-career investigators whose projects align with topics that require greater attention and understanding from researchers, doctors, and patients. In total, the KCA distributed $375,000 in research funds.…

The Metastatic Brain Tumor Collaborative (MBTC), created by the American Brain Tumor Association (ABTA), announced a request for applications for one-year, $50,000 research grants. Faculty – including early-career faculty – are encouraged to apply.  Applicants should propose high-risk, high-impact research projects that will improve the understanding of brain metastasis and have the potential to change current diagnostic or treatment paradigms…

NEW YORK, NY and HOUSTON, TX — The Cancer Research Institute (CRI) is proud to announce a new collaboration with the Kidney Cancer Association (KCA) to fund a CRI  Clinic & Laboratory Integration Program (CLIP) investigator specifically for immunologists and cancer researchers who are pursuing innovative kidney cancer research. CLIP grants are designed to support preclinical and translational research aimed at optimizing cancer immunotherapy…